Cargando…

MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis

The mucin2 (MUC2) mucus barrier acts as the first barrier that prevents direct contact between intestinal bacteria and colonic epithelial cells. Bacterial factors related to the MUC2 mucus barrier play important roles in the response to changes in dietary patterns, MUC2 mucus barrier dysfunction, co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Dianbo, Dai, Wanlin, Dong, Ming, Dai, Chaoliu, Wu, Shuodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671112/ https://www.ncbi.nlm.nih.gov/pubmed/34902790 http://dx.doi.org/10.1016/j.ebiom.2021.103751

Ejemplares similares

Clinical characteristics of the primary hepatic malignant fibrous histiocytoma in China: case report and review of the literature
por: Yao, Dianbo, et al.
Publicado: (2012)

The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal–epithelial transition markers
por: Yao, Dianbo, et al.
Publicado: (2013)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

Gaseous metabolites as therapeutic targets in ulcerative colitis
por: Yao, Chu K, et al.
Publicado: (2023)

Spontaneous Colitis in Muc2-Deficient Mice Reflects Clinical and Cellular Features of Active Ulcerative Colitis
por: Wenzel, Ulf A., et al.
Publicado: (2014)

Diagnosis and Treatment of Male Accessory Breast Cancer: A Comprehensive Systematic Review
por: Pang, Liwei, et al.
Publicado: (2021)

Regulation of Endoplasmic Reticulum Stress-Autophagy: A Potential Therapeutic Target for Ulcerative Colitis
por: Qiao, Dan, et al.
Publicado: (2021)

A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization
por: Yang, Zhihua, et al.
Publicado: (2022)

Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?
por: D’Amico, Ferdinando, et al.
Publicado: (2023)

Transumbilical single-incision laparoscopic distal pancreatectomy: preliminary experience and comparison to conventional multi-port laparoscopic surgery
por: Yao, Dianbo, et al.
Publicado: (2014)

Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis
por: Lin, Wei-Chen, et al.
Publicado: (2017)

Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis
por: Ramos, Laura, et al.
Publicado: (2023)

Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus
por: Mizoshita, Tsutomu, et al.
Publicado: (2013)

Molecular mechanism underlying miR-130b-Sp1 transcriptional regulation in LPS-induced upregulation of MUC5AC in the bile duct epithelium
por: Wu, Xiaodong, et al.
Publicado: (2021)

Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab
por: Puthoor, Pamela R., et al.
Publicado: (2013)

Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission
por: Głąbska, Dominika, et al.
Publicado: (2020)

A review of the therapeutic management of ulcerative colitis
por: Aslam, Nasar, et al.
Publicado: (2022)

The oral bacterial microbiota facilitates the stratification for ulcerative colitis patients with oral ulcers
por: Xu, Jun, et al.
Publicado: (2023)

PSYCHIATRIC FACTORS IN ULCERATIVE COLITIS
por: Chakraborty, P.K., et al.
Publicado: (1983)

Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study
por: Ali, Fares E.M, et al.
Publicado: (2023)

Prediction and Verification of Potential Therapeutic Targets for Non-Responders to Infliximab in Ulcerative Colitis
por: Lyu, Xue, et al.
Publicado: (2023)

Neutrophil elastase stimulates MUC5AC expression in human biliary epithelial cells: a possible pathway of PKC/Nox/ROS
por: Tian, Yu, et al.
Publicado: (2017)

Association of the interleukin-22 genetic polymorphisms with ulcerative colitis
por: Chi, Hong Gang, et al.
Publicado: (2014)

Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis
por: Li, Heng, et al.
Publicado: (2022)

The Distinguishing Bacterial Features From Active and Remission Stages of Ulcerative Colitis Revealed by Paired Fecal Metagenomes
por: Zhu, Ran, et al.
Publicado: (2022)

Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation
por: Zheng, Lie, et al.
Publicado: (2017)

Natural compounds as safe therapeutic options for ulcerative colitis
por: Gupta, Mukta, et al.
Publicado: (2022)

Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis
por: Wu, Yi, et al.
Publicado: (2022)

Effectiveness and safety of central pancreatectomy in benign or low-grade malignant pancreatic body lesions: a systematic review and meta-analysis
por: Bi, Shiyuan, et al.
Publicado: (2023)

Effectiveness of sigmoidoscopy for assessing ulcerative colitis disease activity and therapeutic response
por: Lin, Wei-Chen, et al.
Publicado: (2019)

Mucosal healing and quality of life in therapeutic goals of ulcerative colitis: occurrence and related factors of functional bowel disorder-like symptoms
por: Lin, Lihui, et al.
Publicado: (2022)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
por: Xu, Jun, et al.
Publicado: (2018)

ULCERATIVE COLITIS
Publicado: (1969)

Muc5ac Expression Protects the Colonic Barrier in Experimental Colitis
por: Olli, Kristine E, et al.
Publicado: (2020)

Quyushengxin Formula Causes Differences in Bacterial and Phage Composition in Ulcerative Colitis Patients
por: Yang, Haojie, et al.
Publicado: (2020)

Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2
por: Visschedijk, Marijn C., et al.
Publicado: (2016)

Transumbilical Single-Incision Laparoscopic Resection of Focal Hepatic Lesions
por: Wu, Shuodong, et al.
Publicado: (2014)

Molecular regulation after mucosal injury and regeneration in ulcerative colitis
por: Zheng, Lie, et al.
Publicado: (2022)

Identification of Common Differentially Expressed Genes and Potential Therapeutic Targets in Ulcerative Colitis and Rheumatoid Arthritis
por: Chen, Yueying, et al.
Publicado: (2020)

Cross-species high-resolution transcriptome profiling suggests biomarkers and therapeutic targets for ulcerative colitis
por: Yarani, Reza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_orane6ou2o30jrglfgq0vnhdv2